Click here to discover the largest collection of GeneMedi's Promise-ORF™ ORF/cDNA expression clones
- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected]
Protocol Library Download
 |
 |
Rat Tlr7/RGD1563357 ORF/cDNA clone-Adeno-associate virus(AAV) particle (NM_001097582.1)
Cat. No.: vGMAAV001139
Pre-made Rat Tlr7/RGD1563357 Adeno-associated virus particle for Tlr7 in-vivo study, mechanism of action (MOA) research and Tlr7-associated gene therapy development.
At GM Vector Core (GMVC), we stand at the forefront of custom AAV development and produce distinct grades of AAVs employing state-of-the-art methodologies. Uncover more about our expertise.
MSDS
Product information
| Catalog No. | Product Name | AAV serotype | AAV Grade | AAV quantity |
| vGMAAV001139 | Rat Tlr7 Adeno-associate virus(AAV) particle | AAV1, AAV2, AAV2 variant (Y444F), AAV2 variant (Y272F, Y444F, Y500F, Y730F), AAV2 variant (Y444F, Y730F, Y500F, Y272F, Y704F, Y252F), AAV2 variant(AAV2.7m8), AAV5, AAV6, AAV8, AAV8-1m, AAV8-2m, AAV8 variant (Y733F, Y447F, Y275), AAV9, AAV-Rh.10, AAV-DJ, AAV-DJ/8, AAV-Retro (Retrograde), AAV9-PHP.B, AAV9-PHP.eB, AAV9-PHP.S, AAV-BR1, AAV-2i8, AAV-SIG, AAV-VEC, AAV4, AAV6.2, AAV6.2FF | Pilot Grade | 1.0E+12VG/ml |
| 5.0E+12VG/ml | ||||
| 1E+13VG/ml | ||||
| 5E+13VG/ml | ||||
| 1E+14VG/ml | ||||
| Research Grade | 1.0E+12VG/ml | |||
| 5.0E+12VG/ml | ||||
| 1E+13VG/ml | ||||
| 5E+13VG/ml | ||||
| 1E+14VG/ml | ||||
| GMP-like Grade | inquiry | |||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMAAV001139 |
| Gene Name | Tlr7 |
| Accession Number | NM_001097582.1 |
| Gene ID | 317468 |
| Species | Rat |
| Product Type | Adeno-associate virus(AAV) particle (overexpression) |
| Insert Length | 3153 bp |
| Gene Alias | RGD1563357 |
| Fluorescent Reporter | Null |
| Mammalian Cell Selection | Null |
| Fusion Tag | Null |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGTATTTCCAATGTGGACATTGAAGAGACAAAGTTTTATCTTTTTAAATATGATCTTAGTTTCTAGAGTCCTTGGGTTTCGATGGTATCCTAAAACTCTACCTTGTGATGTCTCTCTCGATAGCACAAACACCCATGTGATTGTGGATTGCACAGACAAGCATTTGACAGAAATACCTGAGGGTATTCCCACTAATACCACCAACCTTACCCTTACCATCAACCACATACCAAGCATCTCTCCAGACTCCTTCCATAGGCTGAAGCATCTGGAGGAGCTTGATTTAAGATGCAACTGTGTACCTATTCTACTGGGGTCCAAAGCCAATGTGTGCACCAAGAGGCTACAGATTAGACCTGGAAGCTTTAGTGGACTCTCTGACTTAAAATCCCTTTACCTGGATGGAAATCAACTTCTAGAGATACCACAGGATCTTCCATCAAGCTTACAGCTTCTGAGCCTTGAGGCTAACAATATCTTCTCCATCACAAAGGAGAATCTATCAGAACTAGTCAACATTGAATCACTCTACCTGGGCCAAAACTGTTATTATCGAAATCCTTGCAATGTTTCCTATTCTATTGAAAAAGATGCTTTCCTAGTTATGAAAAATTTAAAGGTTCTCTCACTAAAAGATAACAATGTCACAGCTGTCCCCACCATTTTGCCACCTAATTTGCTAGAACTCTATCTTTATAACAACATCATTAAGAGAATCCAAGAACATGATTTTAATAAGCTCAGCCAGTTGCAAGTTCTTGACCTAAGTGGAAACTGCCCTCGATGTTATAATGTCCCATATCCATGTACACCATGTGAAAATAATTCTCCCTTACAGATCCATGACAATGCTTTTGATTCATTAACAGAATTAAAAGTTTTACGTCTACACAGTAACTCTCTTCAGCATGTGCCTGCAGAATGGTTTAAAAACATGAGCAACCTCCAGGAACTAGACCTCTCCCAAAACTACTTAGCCAGAGAAATTGAAGAAGCCAAATTTTTGAATTCTCTCCCCAACCTTGTCCAGTTGGATCTGTCTTTCAATTATGAGCTGCAGGTCTACCATGCATCTATTACTTTACCACACTCACTCTCTTCATTGACAAAGTTGAAAAATCTGTATATCAAGGGATATGTCTTTAAAGAGCTGAAAGACTCCAGCCTTTCTGTATTGCACAACCTTTCCAATCTAGAAGTTCTTGACCTTGGCACTAACTTCATAAAAATTGCTGACCTCAACATATTCCAACAGTTTGAAAACCTCAAATTCATAGACCTTTCAGTGAATAAGATATCCCCCTCAGAAGAGTCAAGAGAAGTTGGTTTATGTCCTAATGCCCAAACTTCTGTAGACTGGCACGGACCCCAGGTCCTTGAGGCCTTACACTATTTCCGATATGATGAATATGCACGGAGCTGCAGGTTCAAAAACAAAGAGCCGCCTACTTTTTTGCCTTTGAATGCAGACTGCCACACATATGGGAAGACCTTAGACCTAAGTAGAAATAACATATTTTTTATTAAACCCTCTGATTTTAAGCATCTTTCATTCCTGAAATGCCTCAATTTGTCAGGAAACGCCATTGGCCAAACTCTTAATGGCAGTGAACTCCAGCCCTTGAGAGAGCTGCGGTACTTAGACTTCTCCAACAACCGGCTTGATTTACTCTACTCAACAGCCTTTGAAGAGCTCCAGAATCTGGAAATTCTGGATCTAAGTAGTAACAGCCACTATTTTCAAGCAGAAGGAATTACTCACATGCTAAACTTTACCAAGAAATTACGGCATCTAGAGAAACTCATGATGAATGACAATGACATCTCTACTTCAGCCAGCAGGACCATGGAAAGTGAATCTCTTCGTGTTCTGGAATTCAGAGGCAACCATTTAGATGTTCTATGGAGAGATGGTGATAACAGATACTTGGACTTCTTCAAGAATCTGCTCAACTTAGAGGAATTAGATATCTCCAGAAATTCCCTGAATTCCGTGCCTCCTGGAGTTTTTGAGGGTATGCCACCGAATCTAACGACTCTCTCCTTAGCCAAAAATGGACTCAGATCTTTCTCTTGGGGTAGACTTCAGTTACTAAAGCATTTGAAAAATTTGGACCTCAGCCACAACCAGCTGACAACTGTCCCTGCGAGATTGGCCAACTGTTCCAAAAGTCTCACAAAACTGATTCTTAATCATAATCAAATCAGGCAGTTGACAAAATATTTTCTAGAAGATGCTTTGCAATTGCGCTATCTAGACATCAGTTCAAATAAGATCCAGGTCATTCAGAAGACTAGCTTCCCAGAAAACGTCCTCAACAATCTGAACATGTTGCTTTTACATCACAATCGCTTTCTTTGCAACTGTGATGCTGTGTGGTTTGTCTGGTGGGTTAATCATACAGATGTTACTATTCCATACCTGGCCACTGATGTGACTTGTGCAGGTCCAGGCGCACACAAAGGTCAAAGTGTCATATCTCTGGATCTATATACATGTGAATTAGATCTCACAAACCTGATTCTGTTCTCAGTTTCCATATCATCAGTCCTCTTTCTTATGATAGTTATGACAACAAGTCACCTCTTTTTCTGGGATATGTGGTACATTTATTATTTCTGGAAAGCCAAGATAAAGGGTTATCAACATCTGCAATCAATGGAGTCTTGTTATGATGCTTTTATTGTGTATGACACTAAAAACTCAGCTGTGACAGAATGGGTTTTGCAGGAGCTGGTGGTTAAATTGGAAGACCCAAGAGAAAAACACTTTAATTTGTGTCTAGAAGAAAGAGACTGGCTACCAGGGCAGCCAGTTCTAGAAAACCTTTCCCAGAGCATACAGCTCAGCAGAAAGACAGTGTTTGTGATGACACAGAAATATGCGAAGACTGAGAGTTTTAAGATGGCGTTTTATTTGTCCCATCAGAGGCTTATGGATGAAAAGGTGGATGTGATTATCTTGATATTCTTGGAAAAGCCTCTTCAGAAGTCTAAGTTTCTTCAGCTCCGGAAGAGGCTCTGCAGCAGTTCTGTCCTTGAGTGGCCTACAAATCCACAAGCTCACCCATATTTCTGGCAGTGCCTGAAAAATGCCCTGACTACAGACAATCATGTGGCTTATAGTCAAATGTTCAAGGAAACAGTCTAG |
| ORF Protein Sequence | MVFPMWTLKRQSFIFLNMILVSRVLGFRWYPKTLPCDVSLDSTNTHVIVDCTDKHLTEIPEGIPTNTTNLTLTINHIPSISPDSFHRLKHLEELDLRCNCVPILLGSKANVCTKRLQIRPGSFSGLSDLKSLYLDGNQLLEIPQDLPSSLQLLSLEANNIFSITKENLSELVNIESLYLGQNCYYRNPCNVSYSIEKDAFLVMKNLKVLSLKDNNVTAVPTILPPNLLELYLYNNIIKRIQEHDFNKLSQLQVLDLSGNCPRCYNVPYPCTPCENNSPLQIHDNAFDSLTELKVLRLHSNSLQHVPAEWFKNMSNLQELDLSQNYLAREIEEAKFLNSLPNLVQLDLSFNYELQVYHASITLPHSLSSLTKLKNLYIKGYVFKELKDSSLSVLHNLSNLEVLDLGTNFIKIADLNIFQQFENLKFIDLSVNKISPSEESREVGLCPNAQTSVDWHGPQVLEALHYFRYDEYARSCRFKNKEPPTFLPLNADCHTYGKTLDLSRNNIFFIKPSDFKHLSFLKCLNLSGNAIGQTLNGSELQPLRELRYLDFSNNRLDLLYSTAFEELQNLEILDLSSNSHYFQAEGITHMLNFTKKLRHLEKLMMNDNDISTSASRTMESESLRVLEFRGNHLDVLWRDGDNRYLDFFKNLLNLEELDISRNSLNSVPPGVFEGMPPNLTTLSLAKNGLRSFSWGRLQLLKHLKNLDLSHNQLTTVPARLANCSKSLTKLILNHNQIRQLTKYFLEDALQLRYLDISSNKIQVIQKTSFPENVLNNLNMLLLHHNRFLCNCDAVWFVWWVNHTDVTIPYLATDVTCAGPGAHKGQSVISLDLYTCELDLTNLILFSVSISSVLFLMIVMTTSHLFFWDMWYIYYFWKAKIKGYQHLQSMESCYDAFIVYDTKNSAVTEWVLQELVVKLEDPREKHFNLCLEERDWLPGQPVLENLSQSIQLSRKTVFVMTQKYAKTESFKMAFYLSHQRLMDEKVDVIILIFLEKPLQKSKFLQLRKRLCSSSVLEWPTNPQAHPYFWQCLKNALTTDNHVAYSQMFKETV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| ORF Viral Vector | pGMAAV001139 | Rat Tlr7 Adeno-associate virus(AAV) plasmid |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.